PER 3.85% 13.5¢ percheron therapeutics limited

For General Information, page-1928

  1. 4,391 Posts.
    lightbulb Created with Sketch. 2051
    Sometimes you need to think about the family's of the boys. DMD is a death sentence once diagnosed. Any glimmer of hope will be tightly held onto. I can understand why they as a group would lobby for drug to remain available. The FDA has the fast track pathway in a way of offering hope.

    Interesting timing of the combo study, the patent protection of the combo mode of action and the FDA decision point. Wven the most negative holders must have just a little interest in whats happening now.

    Coincidence or carefully planned? Remember our PI was one of the inventors of this gene therapy.

    Also remember that in the last few years ATL1102 has been positioned as a platform drug for inflammation. Lets not sell its value short as DMD is a very small part of the inflammation market.

    This is almost as exciting as watching Marshy have a tonk with his tin bat. And that doesnt make me old as i am sure we had colour tv by then : )
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.